Bank of Montreal’s Juno Therapeutics, Inc. JUNO Stock Holding History

Bank of Montreal’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-3,300	Closed	-$151K	–	4492
2017 Q4	$151K	Hold	3,300	–	–	﹤0.01%	2808
2017 Q3	$148K	Hold	3,300	–	–	﹤0.01%	2800
2017 Q2	$99K	Hold	3,300	–	–	﹤0.01%	2994
2017 Q1	$73K	Sell	3,300 -3,800	-54%	-$81.5K	﹤0.01%	2947
2016 Q4	$142K	Hold	7,100	–	–	﹤0.01%	2668
2016 Q3	$213K	Buy	+7,100	New	+$221K	﹤0.01%	2442
2016 Q2	–	Sell	-10,700	Closed	-$408K	–	4487
2016 Q1	$408K	Buy	+10,700	New	+$373K	﹤0.01%	2125

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Bank of Montreal's JUNO Position: Q1 2018 in Review

Bank of Montreal sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 7,107 shares — an estimated $325K sold.

Bank of Montreal first reported a position in JUNO in Q4 2015 and held it in 9 quarters. The position peaked at $408K in Q1 2016. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Bank of Montreal reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Bank of Montreal sold 7,107 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $325K.
Bank of Montreal first reported a position in Juno Therapeutics, Inc. in Q4 2015 and held it in 9 quarters.
Bank of Montreal's Juno Therapeutics, Inc. position peaked at $408K in Q1 2016.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Bank of Montreal's 13F filing for Q1 2018, filed 13 Apr 2018.